MicroRNAs and exosomes: promising new biomarkers in acute myeloid leukemias?

Despite advances in understanding of carcinogenesis and of treatment of acute myeloid leukemia, this neoplasm still has a lethality of at least 30%. The search for biomarkers that can predict the response to treatment in the early stages of the disease is still necessary. In recent years, a new form...

Descripción completa

Detalles Bibliográficos
Autores principales: de Araújo, Helena Varela, Sakamoto, Luis Henrique Toshihiro, Bacal, Nydia Strachman, Epelman, Sidnei, Real, Juliana Monte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2022
Materias:
Reviewing Basic Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868825/
https://www.ncbi.nlm.nih.gov/pubmed/35303052
http://dx.doi.org/10.31744/einstein_journal/2022RB5954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868825/
https://www.ncbi.nlm.nih.gov/pubmed/35303052
http://dx.doi.org/10.31744/einstein_journal/2022RB5954

Ejemplares similares